Showing results (1991-2000 of 3,531) with videos related to

Sort By:
Pageof 354
Thoracic Cancer|February 11, 2022
Acute fulminant hepatitis associated with osimertinib administration in a lung cancer patient with chronic hepatitis B: The first mortality case reportYou-Kuang Kang, Fan-Chun Meng
Thoracic Cancer|February 15, 2022
Circ_0010235 facilitates lung cancer development and immune escape by regulating miR-636/PDL1 axisJixing Zhao, Wu Yan, Wencong Huang, et al.
Thoracic Cancer|February 15, 2022
Microwave ablation via a flexible catheter for the treatment of nonsurgical peripheral lung cancer: A pilot studyFangfang Xie, Junxiang Chen, Yifeng Jiang, et al.
Thoracic Cancer|February 16, 2022
Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early-stage large-cell neuroendocrine carcinomaClaudio Andreetti, Mohsen Ibrahim, Antonio Gagliardi, et al.
Thoracic Cancer|January 31, 2022
The deubiquitinase OTUD1 inhibits non-small cell lung cancer progression by deubiquitinating and stabilizing KLF4Xiaoyan Ma, Liming Wang, Guifang Shi, et al.
Thoracic Cancer|February 2, 2022
Knockdown of circ-RAD23B inhibits non-small cell lung cancer progression via the miR-142-3p/MAP4K3 axisQingyang Zhuang, Zhangzhou Huang, Wu Zhuang, et al.
Thoracic Cancer|February 2, 2022
Postoperative radiotherapy for patients with completely resected stage IIIA-N2 non-small cell lung cancer: opt-in or opt-outLucheng Zhu, Bing Xia, Shenglin Ma
Thoracic Cancer|March 18, 2022
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case reportTakuro Yukawa, Yuta Ishida, Yoshio Naomoto, et al.
Thoracic Cancer|March 17, 2022
Circ_0003340 downregulation mitigates esophageal squamous cell carcinoma progression by targeting miR-940/PRKAA1 axisXingzhuo Guan, Xiaohui Guan, Yuanshi Wang, et al.
Thoracic Cancer|April 8, 2022
Postoperative bronchopleural fistula repair: Surgical outcomes and adverse factors for its successYoung Ho Yang, Seong Yong Park, Ha Eun Kim, et al.
Pageof 354